Isolated right ventricular löffler endocarditis secondary to allergic bronchopulmonary aspergillosis

Read full text
Authors: Rikako Horie, Yasuhisa Nakao, Kenta Horie, O. Yamaguchi
Cited by: 0
References: 3

Abstract

A 74-year-old man with a history of chronic productive cough presented with rapidly progressive bilateral leg oedema over one month. Transthoracic echocardiography showed preserved left ventricular systolic function, enlargement of the right atrium and ventricle (Panel A), reduced right ventricular wall motion, and an isoechoic mass at the right ventricular apex (yellow arrowheads in Panel B). Cardiac computed tomography confirmed an apical thrombus (white arrowheads in Panel C), and cardiac magnetic resonance imaging demonstrated delayed enhancement of the right ventricular free wall, predominantly in the endocardial to mid-myocardial layers (red arrowheads in Panel D). Laboratory tests revealed persistent eosinophilia (1000–1500/μL) over the previous five years, and bone marrow examination excluded idiopathic hypereosinophilic syndrome. Chest computed tomography showed a progressive right lower-lobe infiltrate (Panel E, black circle), and bronchoscopy revealed a mucus plug. Aspergillus-specific IgG and IgE antibodies were positive, establishing allergic bronchopulmonary aspergillosis (ABPA) as the underlying cause of secondary eosinophilia. Anticoagulation and corticosteroid therapy led to marked thrombus reduction, normalization of eosinophil counts, and resolution of respiratory and heart failure symptoms. This case highlights that ABPA-related eosinophilia can cause Löffler endocarditis confined to the right ventricle. In contrast to idiopathic hypereosinophilic syndrome—typically associated with aggressive inflammation, biventricular myocardial damage, and extensive intracardiac thrombi—secondary eosinophilia may progress more slowly and be diagnosed while still limited to the right ventricle.1–3 Clinicians should maintain a high index of suspicion for intracardiac thrombus in patients with ABPA, as early identification and appropriate therapy may prevent life-threatening cardiac complications. Rikako Horie (Writing—review & editing [supporting]), Yasuhisa Nakao (Visualization [equal], Writing—review & editing [lead]), Kenta Horie (Writing—review & editing [supporting]), and Osamu Yamaguchi (Writing—review & editing [supporting]) Consent: The authors confirm that written consent has been obtained from the patient for the submission and publication of this case report, including images and associated text, in accordance with the COPE guidelines. None declared. The data underlying this article cannot be shared publicly due to patient privacy concerns. The data are available from the corresponding author upon reasonable request.

Fields of Study & Subjects

Antifungal resistance and susceptibility Infective Endocarditis Diagnosis and Management Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Publication details

Journal / source
European Heart Journal - Case Reports
Volume
10
Issue
2
Pages
ytag003–ytag003
Publication date
7 January 2026
Language
EN